| | | Cancer drug may be associated with increased risk of blood clots
December 4, 2008
"An analysis of randomized, controlled trials indicates that use of bevacizumab (Avastin) is associated with an increased risk of venous thromboembolism, researchers reported in JAMA (2008; 300:2277-85)." | | FDA accepts new drug application for advanced prostate cancer therapy
December 4, 2008
The FDA has accepted the new drug application for a 6-month formulation of triptorelin pamoate (Trelstar), a luteinizing hormone releasing hormone agonist for the palliative treatment of advanced prostate cancer, according to Watson Pharmaceuticals, the drug?s manufacturer. | | Template-guided biopsy delivers higher prostate cancer detection rate
December 4, 2008
Use of a novel template-guided prostate biopsy system potentially produces a higher cancer detection rate and more accurate assessment of grade, according to an article in the British Journal of Urology (2008; 102:546-50). | | Protein inactivation appears to halt prostate tumor progression
December 4, 2008
"Inactivating the expression of GRP78, a specific biomarker for aggressive prostate cancer, appears to block its development in animal models, according to researchers from the University of Southern California, Los Angeles." | | Premature ejaculation agent meets primary endpoints in phase III study
December 4, 2008
A European phase III double-blind placebo controlled study of PSD502, a proprietary formulation of licocaine and prilocaine for the treatment of premature ejaculation, has met its three co-primary endpoints of intra-vaginal ejaculation latency time (IELT) and index of premature ejaculation (IPE), Plethora Solutions Holdings PLC has announced. | |
|  More Articles |
| | | | | How satisfied are your patients?
December 1, 2008
All successful physicians listen to their patients. Do you? | | Health care reformers test 'medical home' service model
December 1, 2008
With a new Congress powered by Democrats and a new Democratic president, sweeping actions affecting health care policy and, particularly, Medicare can be expected in 2009. | | The market meltdown: Is now the time to invest?
December 1, 2008
Now that stocks have lost so much value from where they were, is this a good time to be investing? If so, what's the best approach to take? | | Medicare 2009 payment rules yield winners and losers
December 1, 2008
The 2009 Medicare Physician Fee Schedule final rule was recently published, containing many important changes in reimbursement for urologists. | | How to conduct clear, effective staff evaluations
December 1, 2008
Here are some smart steps physicians and managers can take to make performance reviews easier to conduct and more effective, ultimately paving the way for higher productivity. | |
| | More Articles |
|
Urology Times archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.